publication . Article . 2017

ANTITHROMBOTIC THERAPY IN PATIENTS WITH VALVULAR HEART DISEASE: WHAT'S NEW?

Open Access Russian
  • Published: 01 Dec 2017 Journal: Klinicist, volume 11, issue 2, pages 10-15 (issn: 1818-8338, Copyright policy)
  • Publisher: ABV-press
Abstract
The article presents an overview of modern data and an analysis of the recommendations of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery published in 2017 regarding the use of antithrombotic therapy in patients with valvular heart disease. The results of studies devoted to the use of new oral anticoagulants in patients with valvular heart disease are demonstrated.
Persistent Identifiers
Subjects
Medical Subject Headings: cardiovascular diseasescardiovascular system
free text keywords: heart defects, valvular heart disease, valvular pathology, atrial fibrillation, mitral stenosis, mitral regurgitation, aortic regurgitation, aortic stenosis, warfarin, vitamin k antagonists, new oral anticoagulants, rivaroxaban, apixaban, dabigatran, edoxaban, ablation, lcsh:Medicine, lcsh:R, chemistry.chemical_compound, chemistry, Antithrombotic, Cardiology, medicine.medical_specialty, medicine, medicine.drug, business.industry, business, medicine.disease, Internal medicine
Download fromView all 2 versions
Klinicist
Article . 2017
Klinicist
Article . 2017
Provider: Crossref
Klinicist
Article
Provider: UnpayWall
Any information missing or wrong?Report an Issue